Summary

Allergan, Inc. (Allergan) is a global healthcare company. The company develops and commercializes novel pharmaceuticals, over-the-counter products, biologics and the medical devices addressing ophthalmic, neurological, medical aesthetic, medical dermatology, breast aesthetic, urological, and other specialty markets. The company’s research and development efforts focus on products and technologies related to wide range of specialty areas with significant unmet clinical needs. The company sells its products through a network of own distributors and direct subsidiaries in approximately 40 countries and through independent distributors in about 100 countries across the world. Major customers of the company include wholesalers, drug stores, pharmacies, opticians, merchandisers, food stores, hospitals, and medical practitioners among others. Allergan is headquartered in Irvine, California, the US.

Allergan, Inc. (AGN) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Allergan, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 5
Allergan, Inc., Medical Equipment Deals By Type, 2008 to YTD 2014 6
Allergan, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 7
Allergan, Inc., Medical Equipment, Deals By Market, 2008 to YTD 2014 8
Allergan, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 9
Allergan, Inc., Medical Equipment, Deal Details 10
Asset Purchase 10
Allergan Acquires Aline Hyaluronic Acid Thread Technology From Aline Aesthetics 10
Allergan Acquires Distribution Business In Turkey For US$36.7 Million 11
Venture Financing 12
SkinMedica Secures US$9.4 Million In Financing 12
BAROnova Secures US$7.5 million In Series B Financing 13
BTG Enters Into Licensing Agreement With Allergan 15
Equity Offering 16
MAP Pharma Completes Private Placement Of US$20 Million 16
MAP Pharma Completes Registered Public Offering For US$34 Million 18
Debt Offering 20
Allergan Completes Public Offering Of Senior Unsecured Notes Due 2020 For US$650 Million 20
Asset Transactions 22
Apollo Endosurgery Completes Acquisition Of Obesity Intervention Division Of Allergan For Up To US$110 Million 22
Orthovita Acquires Collagen Raw Material, Equipment And Technology License From Allergan 24
Acquisition 25
SkinMedica Acquires Colorescience, Maker Of Skincare Products 25
Allergan Acquires Precision Light For US$17.9 Million 26
Allergan Completes Acquisition Of Alacer Biomedical 27
Allergan Completes Acquisition Of Serica Technologies 28
Allergan, Inc. - Key Competitors 30
Key Employees 31
Locations And Subsidiaries 32
Head Office 32
Other Locations and Subsidiaries 32
Recent Developments 35
Financial Announcements 35
Feb 05, 2014: Allergan Reports Fourth Quarter 2013 Operating Results 35
Oct 29, 2013: Allergan Reports Third Quarter 2013 Operating Results 36
Oct 04, 2013: Allergan Announces Quarterly Conference Call 38
Jul 31, 2013: Allergan Reports Second Quarter 2013 Operating Results 38
May 01, 2013: Allergan Reports Revenue Of $1.5 Billion In Q1 2013 40
Feb 05, 2013: Allergan Reports Revenue Of $1.5 Billion In Q4 2012 41
Corporate Communications 43
Jun 24, 2013: Allergan Announces Appointment of Douglas S. Ingram as President 43
Government and Public Interest 43
Apr 03, 2013: Allergan Announces Quarterly Conference Call 43
Jan 07, 2013: Allergan Announces Quarterly Conference Call 44
Product News 44
Mar 11, 2014: Natrelle 410 Gel Breast Implants Offer Unique Advantages, Says Los Angeles Plastic Surgeon 44
Feb 06, 2014: Manhattan Plastic Surgeon Reveals Unique Benefits of JUVEDERM VOLUMA XC 45
Jan 23, 2014: Virginia Plastic Surgeon Adopts Innovative New Dermal Filler 45
Jan 22, 2014: FDA Approved Juvederm Voluma is the Newest Anti Aging Dermal Filler 45
Dec 03, 2013: NYC Plastic Surgeon, Dr. Halaas, Announces New Dermal Filler 46
Oct 23, 2013: Adding Multimedia FDA Approves Juvederm VOLUMA XC 47
Jul 31, 2013: Virginia Plastic Surgeon Expands Implant Offerings With Natrelle 410 to Carefully Tailor Breast Augmentation for Each Woman's Unique Body 47
Jun 27, 2013: Dallas Plastic Surgeon Now Offers Allergan's Natrelle 410 Highly Cohesive Silicone-Filled Breast Implants 48
May 02, 2013: FDA Advisory Committee Unanimously Recommends Juvederm Voluma XC As Safe And Effective Treatment Option For Cheek Augmentation To Correct Age-Related Volume Deficit In Mid-Face 49
Mar 21, 2013: Allergan Receives FDA Approval For Natrelle 410 ‘Gummy Bear’ Breast Implant 49
Feb 20, 2013: Allergan Receives FDA Approval For Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants 49
Product Approvals 50
Jan 22, 2014: FDA Approved Juvederm Voluma is the Newest Anti Aging Dermal Filler 50
Oct 23, 2013: Adding Multimedia FDA Approves Juvederm VOLUMA XC 51
Mar 21, 2013: Allergan Receives FDA Approval For Natrelle 410 ‘Gummy Bear’ Breast Implant 52
Feb 20, 2013: Allergan Receives FDA Approval For Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants 52
Appendix 54
Methodology 54
About GlobalData 54
Contact Us 54
Disclaimer 54

List of Tables

Allergan, Inc., Medical Equipment, Key Facts, 2013 1
Allergan, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 1
Allergan, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 1
Allergan, Inc., Medical Equipment, Deals By Market, 2008 to YTD 2014 1
Allergan, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 1
Allergan, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 5
Allergan, Inc., Medical Equipment Deals By Type, 2008 to YTD 2014 6
Allergan, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 7
Allergan, Inc., Deals By Market, 2008 to YTD 2014 8
Allergan, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 9
Allergan Acquires Aline Hyaluronic Acid Thread Technology From Aline Aesthetics 10
Allergan Acquires Distribution Business In Turkey For US$36.7 Million 11
SkinMedica Secures US$9.4 Million In Financing 12
BAROnova Secures US$7.5 million In Series B Financing 13
BTG Enters Into Licensing Agreement With Allergan 15
MAP Pharma Completes Private Placement Of US$20 Million 16
MAP Pharma Completes Registered Public Offering For US$34 Million 18
Allergan Completes Public Offering Of Senior Unsecured Notes Due 2020 For US$650 Million 20
Apollo Endosurgery Completes Acquisition Of Obesity Intervention Division Of Allergan For Up To US$110 Million 22
Orthovita Acquires Collagen Raw Material, Equipment And Technology License From Allergan 24
SkinMedica Acquires Colorescience, Maker Of Skincare Products 25
Allergan Acquires Precision Light For US$17.9 Million 26
Allergan Completes Acquisition Of Alacer Biomedical 27
Allergan Completes Acquisition Of Serica Technologies 28
Allergan, Inc., Key Competitors 30
Allergan, Inc., Key Employees 31
Allergan, Inc., Other Locations 32
Allergan, Inc., Subsidiaries 32

List of Figures

Allergan, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014 1
Allergan, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 5
Allergan, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014 6
Allergan, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 7
Allergan, Inc., Medical Equipment, Deals by Market, 2008 to YTD 2014 8

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Clare

+1 339 368 6001

Purchase Reports From Reputable Market Research Publishers

Wound Management Technologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Wound Management Technologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • July 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

ATS Automation Tooling Systems Inc. (Symbol:ATA) SWOT Analysis, Strategy, Revenues and Profits

ATS Automation Tooling Systems Inc. (Symbol:ATA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • June 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Terumo Cardiovascular Systems Corporation SWOT Analysis, Strategy, Revenues and Profits

Terumo Cardiovascular Systems Corporation SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • July 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.